Ligand Pharmaceuticals Incorporated (LGND) vs Rhythm Pharmaceuticals, Inc. (RYTM)

A side-by-side comparison of Ligand Pharmaceuticals Incorporated and Rhythm Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — LGND vs RYTM

growth of $100 · dividends reinvested · last 9y
LGND +265.1% (+15.5%/yr)RYTM +208.2% (+13.3%/yr)LGND compounded faster over this window
0100200300400Start $1002019202120232025$365$308
LGND RYTM

LGND vs RYTM: by the numbers

  • •RYTM is the larger company ($6.23B vs $5.94B market cap).
  • •LGND is profitable (67.88% net margin) while RYTM runs a net loss (-85.59%).
  • •RYTM grew revenue faster over the past five years (278.53% vs 2.92% CAGR).

Metrics side by side

Valuation

MetricLGNDRYTM
P/E ratio31.72N/A
Forward P/E31.87N/A
P/S ratio20.4625.97
P/B ratio6.1460.50
EV / EBITDA44.97N/A
FCF yield2.21%N/A

Profitability

MetricLGNDRYTM
Gross margin98.58%89.00%
Operating margin17.61%-101.19%
Net margin67.88%-85.59%
ROE20.38%-94.50%
ROIC3.91%-63.96%

Growth (annualized)

MetricLGNDRYTM
Revenue CAGR (5Y)2.92%278.53%
FCF CAGR (5Y)-0.49%N/A
Total return CAGR (5Y)30.72%49.95%

Frequently asked

Which has grown faster, LGND or RYTM?
Over the past five years, RYTM grew revenue faster — LGND at a 2.92% CAGR versus RYTM at 278.53%.
Is LGND or RYTM more profitable?
LGND runs the higher net margin — LGND at 67.88% versus RYTM at -85.59%.
How have LGND and RYTM total returns compared?
Over the past 5 years, LGND delivered 30.72% and RYTM delivered 49.95% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.